Valion Bio (VBIO) Receivables - Net (2020 - 2025)
Valion Bio's Receivables - Net came in at $19,000 for Q3 2025, up 111.1% from $9,000 a year earlier and up 46.2% from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) Receivables - Net (2020 - 2025) Analysis & Trends
At the end of FY2024, Valion Bio's Receivables - Net was $69,000, down 60.3% from FY2023.
- Receivables - Net carries a three-year compound annual growth rate of -9.1% (FY2021 to FY2024).
- Going back by year, Receivables - Net was $174,000 in FY2023 (+62.6%), $107,000 in FY2022 (+16.3%) and $92,000 in FY2021.
- The five-year range for quarterly Receivables - Net is $9,000 (Q3 2024) to $174,000 (Q4 2023).
- Year-over-year, Receivables - Net increased in four of the last eight quarters, with an average decline of 3.5%.
- The fastest year-over-year change in Receivables - Net over five years came in Q3 2025 (growth of 111.1%), and the weakest in Q3 2024 (a decline of 93.1%).
- Business Quant data shows VBIO's Receivables - Net at $13,000 (Q2 2025), $13,000 (Q1 2025) and $69,000 (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 174,000.00 |
| Sep 30, 2023 | 131,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 117,000.00 |
| Dec 31, 2021 | 92,000.00 |
| Dec 31, 2020 | 52,000.00 |
API Access
Valion Bio Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();